Germany bars antibiotic drug from Ranbaxy’s central India plant
MUMBAI (Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd has been barred by from exporting the antibiotic cephalosporin to Germany from its plant in central India for not complying with standard manufacturing practices. Germany's regulator issued a "non-compliance" report for the plant where Ranbaxy made the antibiotic, after an inspection in June, the European Medicines Agency said on its website in a notice dated Nov. 26. …
